Institute for the Experimental Endocrinology and Oncology, National Research Council of Italy, Via Tommaso de Amicis 95, 80145 Naples, Italy.
Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK.
Curr Opin Genet Dev. 2021 Dec;71:106-113. doi: 10.1016/j.gde.2021.07.005. Epub 2021 Jul 31.
PARP1 and PARP2 govern the DNA-damage response by catalysing the reversible post-translational modification ADP-ribosylation. During the repair of DNA lesions, PARP1 and PARP2 combine with an accessory factor HPF1, which is required for the modification of target proteins on serine residues. Although the physiological role of individual ADP-ribosylation sites is still unclear, serine ADP-ribosylation at damage sites leads to the recruitment of chromatin remodellers and repair factors to ensure efficient DNA repair. ADP-ribosylation signalling is tightly controlled by the coordinated activities of (ADP-ribosyl)glycohydrolases PARG and ARH3 that, by reversing the modification, guarantee proper kinetics of DNA repair and cell cycle re-entry. The recent advances in the structural and mechanistic understanding of ADP-ribosylation provide new insights into human physiopathology and cancer therapy.
PARP1 和 PARP2 通过催化可逆的翻译后修饰 ADP-ribosylation 来调控 DNA 损伤反应。在 DNA 损伤修复过程中,PARP1 和 PARP2 与辅助因子 HPF1 结合,后者对于丝氨酸残基上靶蛋白的修饰是必需的。尽管单个 ADP-ribosylation 位点的生理作用尚不清楚,但损伤部位的丝氨酸 ADP-ribosylation 导致染色质重塑因子和修复因子的募集,以确保有效的 DNA 修复。ADP-ribosylation 信号通过(ADP-ribosyl)糖基水解酶 PARG 和 ARH3 的协调活动来严格控制,它们通过逆转修饰,保证 DNA 修复和细胞周期再进入的适当动力学。ADP-ribosylation 的结构和机制理解的最新进展为人类病理生理学和癌症治疗提供了新的见解。